Navigation Links
Mount Sinai recognized as Center of Excellence for Research in Alzheimer's disease
Date:10/10/2007

Mount Sinai School of Medicine has just received a major grant from the National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health (NIH) and lead Federal agency for research on complementary and alternative medicine. This new grant creates a Center of Excellence for Research in Complementary and Alternative Medicine at Mount Sinai that will focus on Alzheimers disease. The new Center has been awarded an estimated $8 million grant over the next five years to continue its research and study of "age defying diets." There will be an emphasis on grape-derived compounds that may be able to delay or possibly prevent the onset of Alzheimers disease .

The new Center will systematically explore, through basic and preclinical research, the idea that a longer, disease-free life isn't necessarily only in our genes but also partly in our hands depending upon our lifestyles, said principal investigator of the new Centers research- Dr. Giulio Maria Pasinetti, M.D., Ph.D. Professor of Psychiatry and Neuroscience, Geriatrics and Adult Development & Director of Neuroinflammation Research Center in Department of Psychiatry at Mount Sinai School of Medicine.

Protective roles of dietary grape-derived compounds in Alzheimers disease will be the focus of new research at the Center at Mount Sinai. Preclinical studies will be conducted to identify natural compounds extracted from grapes, known as polyphenols that might have a protective role in Alzheimers disease. Using mice genetically modified to develop Alzheimers disease-type neuropathology and memory loss, researchers led by Dr. Pasinetti will investigate the biological mechanisms by which these grape-derived compounds may affect changes in the brain that are characteristic of Alzheimers disease and associated with cognitive decline.

NCCAM has just added three new Centers of Excellence for Research on Complementary and Alternative Medicine (CAM) to its centers program including Mount Sinais. The two other new Centers include- UCLAs Center of Excellence in Pancreatic Diseases and University of South Carolina Research Foundations Center for CAM Research on Autoimmune and Inflammatory Diseases

The addition of these centers increases the robustness of our Centers of Excellence research program and confirms our continuing commitment to rigorous CAM research, said Ruth L. Kirschstein, M.D., NCCAM Acting Director. These multidisciplinary research teams will work to uncover new insights or novel treatments for health conditions that affect many people. The science conducted will be key to understanding what CAM approaches may or may not work and informing the integration of effective CAM practices into the health care delivery system.

It is an exciting program. We hope the research results from this new program will eventually open new research areas at Mount Sinai School of Medicine including involving the role of identifying personalized medicine in relation to lifestyle factors in the prevention of Alzheimer's disease, said Dr. Pasinetti. We look forward to this opportunity to continue a natural compound discovery program, where we are able to identify novel natural compounds, primarily grape derived - for the prevention or treatment of Alzheimer's disease.


'/>"/>

Contact: Mount Sinai Newsroom
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Related medicine news :

1. Drinking adequate amounts of water
2. Mountain biking connected to infertility
3. Reduced fertility in men who mountain bike
4. The Benefits Of A Diet Consisting Of Moderate Amounts Of Fat
5. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
6. Epidemic Fear In Mumbai Mounting Post-Floods
7. Non-Communicable Diseases Mounting Up At An Alarming Rate in India
8. Illegal Drug Use In England Mounting Up At An Alarming Rate
9. Indonesia Has Ninth Bird-Flu Death as Risk Mounts
10. Surgeons being paid triple the amount to cut waiting lists
11. Mountain Biking Results In Serious Injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: